A similar phenomenon is also observed in multiple myeloma, that CD9 may increase tumor proliferation through increasing the ability of the HB-EGF/EGF receptor and CD9 may contribute to the proliferation of tumor cells by associating with HB-EGF on cell membranes (50). This evidence concerns the gene HBEGF and plasma cell myeloma.